On-chip micro-flow polystyrene bead-based immunoassay for quantitative detection of tacrolimus (FK506)

Analytical Biochemistry

Volumn 334, Issue 1, 2004, Pages 111-116

  Murakami, Yoshihiro ^a,b,d   Endo, Tatsuro ^a   Yamamura, Shouhei ^a   Nagatani, Naoki ^c   Takamura, Yuzuru ^a   Tamiya, Eiichi ^a  

^a JAPAN ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY   (Japan)

^b ASTELLAS PHARMA INC   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^d Med and Pharmacol Res Ctr Found   (Japan)

Author keywords

Blood concentration; Competitive immunoassay; Microfluidics; Tacrolimus (FK506); Therapeutic drug monitoring

Indexed keywords

ANTIBODIES; BLOOD; CHANNEL FLOW; DRUG DOSAGE; MICROCHANNELS; MICROFLUIDICS; PATIENT MONITORING; POLYSTYRENES;

BLOOD CONCENTRATIONS; COMPETITIVE IMMUNOASSAY; FLUOROGENIC SUBSTRATE; MICRO-FLUIDIC DEVICES; POLYDIMETHYLSILOXANE PDMS; QUANTITATIVE DETECTION; TACROLIMUS; THERAPEUTIC DRUG MONITORING;

IMMUNOLOGY;

ANTIBODY; DIMETICONE; TACROLIMUS;

ACCURACY; ARTICLE; ASSAY; CHEMICAL REACTION; CHIP MICROFLOW POLYSTYRENE BEAD BASED IMMUNOASSAY; DEVICE; DRUG DETERMINATION; DRUG MONITORING; FEASIBILITY STUDY; FLOW; FLUORESCENCE; IMMUNOASSAY; LIQUID; MATERIAL COATING; MICROSCOPE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

EID: 4644251591     PISSN: 00032697     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ab.2004.07.029     Document Type: Article

References (19)

1. J. Fung, K. Abu-Elmagd, A. Jain, R. Gordon, A. Tzakis, S. Todo, S. Takaya, M. Alessiani, A. Demetris, and O. Bronster A randomized trial of primary liver transplantation under immunosuppression with FK506 vs cyclosporine Transplant. Proc. 23 1991 2977 2983
2. T.E. Starzl, S. Todo, J. Fung, A.J. Demetris, R. Venkataramman, and A. Jain FK506 for liver, kidney, and pancreas transplantation Lancet 2 1989 1000 1004
3. G.B. Klintmalm Fk 506: an update Clin. Transplant. 8 1994 207 210
4. D.H. Peters, A. Fitton, G.L. Plosker, and D. Faulds Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation Drugs 46 1993 746 794
5. N.A. Undre, P. Stevenson, and A. Schafer Pharmacokinetics of tacrolimus: clinically relevant aspects Transplant. Proc. 31 1999 21S 24S
6. J.P. van Hooff, J.M. Boots, E.M. van Duijnhoven, and M.H. Christiaans Dosing and management guidelines for tacrolimus in renal transplant patients Transplant. Proc. 31 1999 54S 57S
7. K. Tamura, M. Kobayashi, K. Hashimoto, K. Kojima, K. Nagase, K. Iwasaki, T. Kaizu, H. Tanaka, and M. Niwa A highly sensitive method to assay FK506 levels in plasma Transplant. Proc. 19 1987 23 29
8. F.C. Grenier, J. Luczkiw, M. Bergmann, S. Lunetta, M. Morrison, D. Blonski, K. Shoemaker, and M. Kobayashi A whole blood FK506 assay for the IMx analyzer Transplant. Proc. 23 1991 2748 2749
9. I. Firdaous, A. Hassoun, J.B. Otte, R. Reding, J.P. Squifflet, T. Besse, and P.E. Wallemacq HPLC-microparticle enzyme immunoassay specific for tacrolimus in whole blood of hepatic and renal transplant patients Clin. Chem. 41 1995 1292 1296
10. W.J. Jusko Analysis of tacrolimus (FK506) in relation to therapeutic drug monitoring Ther. Drug Monit. 17 1995 596 601
11. G. MacFarlane, D. Scheller, D. Ersfeld, T. Jensen, A. Jevans, P.Y. Wong, and M. Kobayashi A simplified whole blood enzyme-linked immunosorbent assay (Pro-Trac II) for tacrolimus (FK506) using proteolytic extraction in place of organic solvents Ther. Drug Monit. 18 1996 698 705
12. D.W. Stephen, P. Rooke, S. Clark, M. Coutts, L. Crowe, and D. Docherty Evaluation of the dade behring syva emit 2000 tacrolimus assay on the Bayer Advia 1650 Ann. Clin. Biochem. 40 2003 697 700
13. A.K. Gonschior, U. Christians, M. Winkler, H.M. Schiebel, A. Linck, and K.F. Sewing Simplified high-performance liquid chromatography-mass spectrometry assay for measurement of tacrolimus and its metabolites and cross-validation with microparticle enzyme immunoassay Ther. Drug Monit. 17 1995 504 510
14. A.M. Alak, S. Moy, M. Cook, P. Lizak, A. Niggebiugge, S. Menard, and A. Chilton An HPLC/MS/MS assay for tacrolimus in patient blood samples. Correlation with results of an ELISA assay J. Pharm. Biomed. Anal. 16 1997 7 13
15. C.E. Staatz, P.J. Taylor, and S.E. Tett Comparison of an ELISA and an LC/MS/MS method for measuring tacrolimus concentrations and making dosage decisions in transplant recipients Ther. Drug Monit. 24 2002 607 615
16. J.L. Cogill, P.J. Taylor, I.S. Westley, R.G. Morris, S.V. Lynch, and A.G. Johnson Evaluation of the tacrolimus ii microparticle enzyme immunoassay (MEIA II) in liver and renal transplant recipients Clin. Chem. 44 1998 1942 1946
17. J. Dietemann, P. Berthoux, J.P. Gay-Montchamp, M. Batie, and F. Berthoux Comparison of ELISA method versus MEIA method for daily practice in the therapeutic monitoring of tacrolimus Nephrol. Dial. Transplant. 16 2001 2246 2249
18. A.T. Gewirtz, and S.V. Sitaraman Tacrolimus fujisawa Curr. Opin. Investig. Drugs 3 2002 1307 1311
19. Y. Murakami, H. Takamatsu, A. Noda, K. Osoda, R. Ichise, M. Tatsumi, K. Tabata, T. Sawamoto, S. Nishimura, Pharmacokinetic animal PET study for FK506 as a potent neuroprotective agent, J. Nucl. Med. 2004 (in press)